Tech Company Financing Transactions

Tempo Therapeutics Funding Round

Galaxy-Sirius Partners, Johnson & Johnson Innovation and private investors invested in a $12 million Series A funding round for Tempo Therapeutics. The financing round was announced by the company on 3/19/2024.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Healthcare Services

Mailing Address

3030 Bunker Hill Street 104
San Diego, CA 92109
USA

Phone

(619) 202-7445

Website

www.tempothera.com

Email Address

[email protected]

Overview

Tempo Therapeutics, headquartered in San Diego, California, is pioneering a new era in tissue engineering biotechnology, using our proprietary MAP material science technology. Using MAP technology, we are building functional tissue and organs within patients to treat disease.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Westbrook Weaver

        

Chief Scientific Officer

Donald Griffin

        

VP - Finance

Shelly Vandertie

        

VP - Product Management

Sam Timko

        

VP - R & D

Stephanie Deshayes

        

Browse more venture capital transactions:

Prev: 3/19/2024: Ascent Platform venture capital transaction
Next: 3/19/2024: Euno venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC transactions reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary